Atrium Health Sanger Heart and Vascular Institute has hit a milestone in heart care, having performed 2,022 transcatheter aortic valve replacements (TAVR).
News | Structural Heart
Atrium Health Sanger Heart and Vascular Institute Marks Milestone Surgery

August 9, 2022 — Atrium Health Sanger Heart and Vascular Institute has hit a milestone in heart care, having performed 2 ...

Home August 09, 2022
Home
Butterfly Medical Announces First BPH Clinical Study Procedures Performed in North America for its Next Generation Minimally Invasive Solution
News | Cardiovascular Ultrasound
Butterfly Medical Announces First BPH Clinical Study Procedures Performed in North America for its Next Generation Minimally Invasive Solution

August 9, 2022 — Butterfly Medical, an Israeli medical device company developing a novel minimally invasive solution to ...

Home August 09, 2022
Home
Effect of chronic reductive stress on myocardial proteome.
News | Cardiovascular Clinical Studies
The Protein Signature Changes During Heart Disease Caused by Reductive Stress 

August 8, 2022 — Two years ago, University of Alabama at Birmingham researchers and colleagues reported that reductive ...

Home August 08, 2022
Home
The condition is known to increase the risk of cardiovascular disease and atherosclerosis, a buildup of fats inside the blood vessels that can constrict blood flow to the body’s tissues.
News | Heart Failure
Study Reverses Long-Held Ideas About Relationship Among Diabetes, Fat and Cardiovascular Disease

August 8, 2022 — A major risk factor for diabetes, insulin resistance occurs when the cells of the body do not respond ...

Home August 08, 2022
Home
The illustration shows a portion of the receptor pGC-A, known as the extracellular domain, which protrudes from cell surfaces in the cardiovascular system. Small molecules bind with the receptor and exert subtle control over blood pressure. The new research offers the first sneak peek at the full-length receptor, a vital step in the development of new drugs to treat hypertension and other afflictions.
News | Hypertension
New Study Explores Cell Receptor Crucial for Cardiovascular Health

August 8, 2022 — Cardiovascular diseases remain a leading cause of death around the world. A primary contributor to ...

Home August 08, 2022
Home
Images of cardiology leadership receiving their first doses of the COVID-19 vaccine in late December. Left, American Society of Nuclear Cardiology (ASNC) President Randy Thompson, M.D., at Saint Luke's Hospital in Kansas City. Center, former American Society of Echocardiography (ASE) president Madhav Swaminathan, M.D., Duke University. Right, Thomas Maddox, M.D., administers doses of the COVID vaccine at the Washington University School of Medicine. #COVID19 #Sarscov2 #COVIDvaccine
Gallery | Coronavirus (COVID-19) | Dave Fornell and Melinda Taschetta-Millane
Image Gallery Showing Impact of the COVID-19 Pandemic

This photo gallery is designed to show the impact of the novel coronavirus (COVID-19, SARS-CoV-2) on both healthcare and ...

Home August 08, 2022
Home
For people with coronary heart disease, beta-blockers can improve survival and quality of life, while aspirin and other antiplatelet medications can reduce the risk of a heart attack.
News | Heart Failure
Two Heart Medications Tied to Greater Heart-attack Risk During Very Hot Weather

August 5, 2022 — For people with coronary heart disease, beta-blockers can improve survival and quality of life, while ...

Home August 05, 2022
Home
Frank Van Hyfte, VP of Europe, the Middle East and Africa
News | Cardiovascular Business
Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline

August 5, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 05, 2022
Home
Providers’ differential decision-making must be addressed to equalize chance of survival for heart failure patients, researchers say
News | Ventricular Assist Devices (VAD)
When Heart-assisting Implants Could Save a Life, Black, Female Patients Don’t Get Them as Often 

August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a ...

Home August 05, 2022
Home
Impact of the United States Supreme Court Reversal of Roe vs. Wade for patients with heart rhythm conditions
News | HRS
HRS Statement on Reversal of Roe v. Wade and HRS2023 in New Orleans

August 4, 2022 — The Heart Rhythm Society (HRS) is a professional society representing a diverse population of ...

Home August 04, 2022
Home
The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical science that will be presented at TCT 2022. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine.
News | TCT
CRF Announces TCT 2022 Late-breaking Clinical Science

August 4, 2022 — The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical science that will ...

Home August 04, 2022
Home
The Global Defibrillator Market size was valued at $11.30 billion in 2021 and is predicted to reach $21.09 billion by 2030
News | Defibrillator Monitors
Defibrillator Market Size Projected to Reach $21B by 2030

August 3, 2022 — A defibrillator administers a therapeutic shock to a patient's heart in life-threatening circumstances ...

Home August 03, 2022
Home
Christopher White, MD, System Chairman for Cardiovascular Disease Director and Director of John Ochsner Heart & Vascular Institute
News | Stents Carotid
JACC Study Makes Case for Expanding Coverage for Carotid Artery Stenting

August 3, 2022 — Research from Ochsner Health published in the Journal of the American College of Cardiology is likely ...

Home August 03, 2022
Home
Valentin Fuster, MD, PhD
News | TCT
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)

August 2, 2022 — Two significant awards will be presented at TCT 2022, to be held in Boston, Sept. 16-19, 2022. Career ...

Home August 02, 2022
Home
An advanced form of cardiac MRI, developed by academics at UCL in collaboration with the Royal Free Hospital, has for the first-time enabled clinicians to measure the effectiveness of chemotherapy in patients with the life-limiting condition ‘stiff heart syndrome’.
News | Magnetic Resonance Imaging (MRI)
Advanced MRI benefits Patients with Heart Stiffening Disease

August 2, 2022 — An advanced form of cardiac MRI, developed by academics at UCL in collaboration with the Royal Free ...

Home August 02, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now